EDQM approves EstechPharma’s acamprosate calcium
With the EDQM’s approval of acamprosate calcium, the company is poised to make quicker inroads to the European market.
The EDQM is responsible for facilita...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
